Answers are grounded in this paper and cite their sources.
Observational analysis highlights improved diagnostic precision and treatment adherence in depression care, suggesting AI tools may reduce stigma.
UNSTRUCTURED Depression remains underdiagnosed in many Asian populations, largely due to stigma, limited illness insight, and reliance on subjective self-report instruments. The Stress electroencephalography (EEG) Assessment (SEA) SystemTM is an AI-driven EEG tool approved by the Taiwan regulatory authority. It generates an objective, user-friendly index from just 90 seconds of resting-state EEG data to assist in the diagnosis of major depressive disorder (MDD). This article presents three clinical cases illustrating how SEA can enhance diagnostic clarity, facilitate patients and family understanding, and uncover otherwise unrecognized depressive symptoms. In each case, the availability of objective neurophysiological data to support clearer clinical communication, improve treatment adherence, or inform critical diagnostic and therapeutic decisions. Unlike conventional EEG systems, SEA is intuitive, rapid, and operable by non-specialists, making it feasible for integration into primary care, geriatric medicine, and wellness or preventive settings. By framing depression as a biological and measurable brain condition, SEA may help reduce stigma, promote early help-seeking, and reshape clinical dialogue between patients, families, and healthcare providers. Integrating this technology into psychiatric practice holds promise for strengthening shared decision-making and optimizing care pathway. Further research is warranted to evaluate its long-term clinical effectiveness and impact on patient outcomes.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: